Long intergenic non-protein coding RNA 896 (LINC00896)

Long intergenic non-protein coding RNA 896 (LINC00896) is a human long non-coding RNA transcribed from chromosome 22 (22q11.2). LINC00896 has been implicated in pathological contexts including chromosome 22q11.2 deletion syndrome, where its deletion may contribute to multi-organ defects. In cancer settings, particularly colon adenocarcinoma and lung squamous cell carcinoma, it is part of genomic instability signatures and may serve as a prognostic biomarker. Its dysregulation correlates with increased PD-L1 expression and higher mutation rates, suggesting a possible indicator for immunotherapy sensitivity. No direct therapeutic agents or molecular interactions have been reported for this RNA, and its principal biological functions and therapeutic relevance remain under investigation[1][2][9][11][12].\n\nIf more granularity or specific mechanistic details are required, current public annotations, experimental characterization, and clinical evidence remain limited. Most functional information remains indirect, inferred from high-throughput expression or association studies, not from direct molecular targeting.

Other names

LINC00896FLJ32575

Not applicable; no drugs directly target this lncRNA